ID   2C6F3
AC   CVCL_C5D5
DR   ABCD; ABCD_AF651
DR   Wikidata; Q116047998
RX   Patent=US10259884;
RX   PubMed=27270318;
CC   Group: Patented cell line.
CC   Biotechnology: When conjugated to a radioisotope, the monoclonal antibody produced by this hybridoma can be used as a radio-immunoconjugate for the treatment of lung cancer models in mice (PubMed=27270318).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O14907; Human TAX1BP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
RX   Patent=US10259884;
RA   Hallahan D.E., Yan H.-P.;
RT   "Antibodies to GRP78.";
RL   Patent number US10259884, 16-Apr-2019.
//
RX   PubMed=27270318; DOI=10.18632/oncotarget.9713;
RA   Yan H.-P., Kapoor V., Nguyen K., Akers W.J., Li H., Scott J.,
RA   Laforest R., Rogers B.E., Thotala D., Hallahan D.E.;
RT   "Anti-tax interacting protein-1 (TIP-1) monoclonal antibody targets
RT   human cancers.";
RL   Oncotarget 7:43352-43362(2016).
//